Alan Kay

2.3k total citations
51 papers, 1.8k citations indexed

About

Alan Kay is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Alan Kay has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Epidemiology, 32 papers in Hepatology and 10 papers in Molecular Biology. Recurrent topics in Alan Kay's work include Hepatitis B Virus Studies (40 papers), Hepatitis C virus research (31 papers) and Hepatitis Viruses Studies and Epidemiology (10 papers). Alan Kay is often cited by papers focused on Hepatitis B Virus Studies (40 papers), Hepatitis C virus research (31 papers) and Hepatitis Viruses Studies and Epidemiology (10 papers). Alan Kay collaborates with scholars based in France, Brazil and United States. Alan Kay's co-authors include Fabien Zoulim, Francis Galibert, Elisabeth Mandart, Christian Trépo, Isabelle Chemin, Christian Trépo, Bernard Mandrand, Lucyna Cova, C. Trépo and M. Grunberg‐Manago and has published in prestigious journals such as Nucleic Acids Research, The EMBO Journal and Hepatology.

In The Last Decade

Alan Kay

50 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Kay France 23 1.6k 1.2k 347 293 169 51 1.8k
Elisabeth Mandart France 14 1.4k 0.9× 742 0.6× 439 1.3× 589 2.0× 238 1.4× 20 1.8k
Josef Köck Germany 27 1.4k 0.9× 888 0.8× 349 1.0× 436 1.5× 91 0.5× 45 1.8k
Allison R. Jilbert Australia 32 2.3k 1.5× 1.7k 1.4× 684 2.0× 265 0.9× 330 2.0× 68 2.6k
Akihisa Takamizawa Japan 19 1.0k 0.7× 1.0k 0.9× 379 1.1× 321 1.1× 169 1.0× 43 1.9k
Volker Bruss Germany 29 2.6k 1.6× 1.9k 1.6× 572 1.6× 458 1.6× 130 0.8× 43 2.8k
René Rijnbrand United States 27 768 0.5× 818 0.7× 567 1.6× 756 2.6× 268 1.6× 50 2.2k
Roger Ling United Kingdom 22 968 0.6× 948 0.8× 938 2.7× 154 0.5× 144 0.9× 34 1.7k
Scott Muerhoff United States 5 1.5k 1.0× 1.6k 1.4× 586 1.7× 137 0.5× 144 0.9× 5 2.2k
Kevin L. McKnight United States 18 486 0.3× 587 0.5× 765 2.2× 630 2.2× 181 1.1× 32 1.8k
Simon P. Fletcher United States 27 1.8k 1.2× 1.5k 1.3× 398 1.1× 928 3.2× 99 0.6× 59 3.0k

Countries citing papers authored by Alan Kay

Since Specialization
Citations

This map shows the geographic impact of Alan Kay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Kay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Kay more than expected).

Fields of papers citing papers by Alan Kay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Kay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Kay. The network helps show where Alan Kay may publish in the future.

Co-authorship network of co-authors of Alan Kay

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Kay. A scholar is included among the top collaborators of Alan Kay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Kay. Alan Kay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gomes, Selma A., et al.. (2013). Improved rolling circle amplification (RCA) of hepatitis B virus (HBV) relaxed-circular serum DNA (RC-DNA). Journal of Virological Methods. 193(2). 653–659. 30 indexed citations
2.
Hayer, Juliette, et al.. (2012). HBVdb: a knowledge database for Hepatitis B Virus. Nucleic Acids Research. 41(D1). D566–D570. 144 indexed citations
3.
Cotte, Laurent, Mary‐Anne Trabaud, Christian Trépo, et al.. (2012). Probable Corticosteroid-Induced Reactivation of Latent Hepatitis B Virus Infection in an HIV-Positive Patient Involving Immune Escape. The Journal of Infectious Diseases. 205(11). 1757–1761. 17 indexed citations
4.
Araújo, Natalia M., et al.. (2011). Hepatitis B virus infection from an evolutionary point of view: How viral, host, and environmental factors shape genotypes and subgenotypes. Infection Genetics and Evolution. 11(6). 1199–1207. 58 indexed citations
5.
Chemin, Isabelle, Bernard Mandrand, Albert Tran, et al.. (2004). Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays. Journal of Medical Virology. 73(4). 508–515. 73 indexed citations
6.
Chemin, Isabelle, et al.. (2002). Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient. Hepatology. 35(5). 1215–1224. 51 indexed citations
7.
Chemin, Isabelle, Fabien Zoulim, Philippe Merle, et al.. (2001). High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. Journal of Hepatology. 34(3). 447–454. 141 indexed citations
8.
Borel, Christelle, Olivier Schorr, Isabelle Durand, et al.. (2001). Initial Amplification of Duck Hepatitis B Virus Covalently Closed Circular Dna After In Vitro Infection of Embryonic Duck Hepatocytes Is Increased by Cell Cycle Progression. Hepatology. 34(1). 168–179. 18 indexed citations
9.
Chemin, Isabelle, et al.. (2001). Role of silent hepatitis B virus in chronic hepatitis B surface antigen(−) liver disease. Antiviral Research. 52(2). 117–123. 42 indexed citations
10.
Silva, Luciano Kalabric, Raymundo Paraná, Sérgio Pinto de Souza, et al.. (2000). Hepatitis C virus genotypes in a northeastern area of Brazil.. American Journal of Tropical Medicine and Hygiene. 62(2). 257–260. 37 indexed citations
11.
Borel, Christelle, Claire Sunyach, O. Hantz, C. Trépo, & Alan Kay. (1998). Phosphorylation of DHBV Pre-S: Identification of the Major Site of Phosphorylation and Effects of Mutations on the Virus Life Cycle. Virology. 242(1). 90–98. 20 indexed citations
12.
Pichoud, Christian, et al.. (1998). A novel vector for the study of hepatitis delta virus replication. Journal of Virological Methods. 70(1). 19–28. 3 indexed citations
13.
Sunyach, Claire, et al.. (1997). In VivoSelection of Duck Hepatitis B Virus Pre-S Variants Which Escape from Neutralization. Virology. 234(2). 291–299. 9 indexed citations
14.
Mandart, Elisabeth, et al.. (1994). Woodchuck hepatitis virus surface antigen produced in vitro fails to bind polymerized woodchuck serum albumin. Journal of General Virology. 75(8). 2081–2084. 2 indexed citations
15.
Lambert, Véronique, Alan Kay, Catherine Godinot, et al.. (1993). Fine Mapping of Neutralization Epitopes on Duck Hepatitis B Virus (DHBV) pre-S Protein Using Monoclonal Antibodies and Overlapping Peptides. Virology. 192(1). 217–223. 27 indexed citations
16.
Lambert, Véronique, et al.. (1993). Duck hepatitis B virus (DHBV) as a model for understanding hepadnavirus neutralization. PubMed. 8. 133–139. 2 indexed citations
17.
Lambert, Véronique, et al.. (1991). In vivo neutralization of duck hepatitis B virus by antibodies specific to the N-terminal portion of pre-S protein. Virology. 185(1). 446–450. 23 indexed citations
18.
Kupiec, Jean-Jacques, et al.. (1991). Sequence analysis of the simian foamy virus type 1 genome. Gene. 101(2). 185–194. 57 indexed citations
20.
Kay, Alan & M. Grunberg‐Manago. (1972). The mechanism of action of initiation factor IF1: Non-analogy with elongation factor EFTs. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 277(1). 225–230. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026